Physician profile
Billy J Cook
NPI 1629060199
$2,036.23
in general payments reported to CMS, 2019-2025
12 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $18.22 · 2021: $256 · 2022: $385 · 2023: $566 · 2024: $336 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $389.33 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Johnson & Johnson Vision Care, INC. | $385.21 | 2019-2025 | Acuvue |
| Abbvie INC. | $336.64 | 2022-2025 | Vuity, Lumigan |
| Novartis Pharmaceuticals Corporation | $229.54 | 2020-2023 | |
| Alcon Vision LLC | $227.59 | 2019-2025 | Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $224.48 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $68.98 | 2021-2025 | |
| Astellas Pharma US INC | $56.19 | 2023 | |
| Biotissue Holdings INC. | $42.46 | 2025 | |
| Allergan, INC. | $29.47 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $26.47 | 2024 | Xdemvy |
| Horizon Therapeutics Plc | $19.87 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.